Switch theme
Sign up to access all valuation multiples
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
2003
354
LTM Revenue $116M
LTM EBITDA -$64.6M
$237M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Outset Medical has a last 12-month revenue of $116M and a last 12-month EBITDA of -$64.6M.
In the most recent fiscal year, Outset Medical achieved revenue of $114M and an EBITDA of -$97.9M.
Outset Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Outset Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $130M | $114M | XXX | XXX | XXX |
| Gross Profit | $17.8M | $29.0M | XXX | XXX | XXX |
| Gross Margin | 14% | 26% | XXX | XXX | XXX |
| EBITDA | -$154M | -$97.9M | XXX | XXX | XXX |
| EBITDA Margin | -118% | -86% | XXX | XXX | XXX |
| Net Profit | -$163M | -$173M | XXX | XXX | XXX |
| Net Margin | -125% | -152% | XXX | XXX | XXX |
| Net Debt | $23.1M | $61.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 18, 2025, Outset Medical's stock price is $11.
Outset Medical has current market cap of $193M, and EV of $237M.
See Outset Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $237M | $193M | XXX | XXX | XXX | XXX | $-19.95 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 18, 2025, Outset Medical has market cap of $193M and EV of $237M.
Outset Medical's trades at 2.0x LTM EV/Revenue multiple, and -3.7x LTM EBITDA.
Analysts estimate Outset Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Outset Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $237M | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | -2.4x | XXX | XXX | XXX |
| P/E | -1.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -2.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOutset Medical's NTM/LTM revenue growth is 8%
Outset Medical's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Outset Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Outset Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Outset Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -13% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -86% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -36% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -78% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 62% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 38% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 34% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 134% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Outset Medical acquired XXX companies to date.
Last acquisition by Outset Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Outset Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Outset Medical founded? | Outset Medical was founded in 2003. |
| Where is Outset Medical headquartered? | Outset Medical is headquartered in United States of America. |
| How many employees does Outset Medical have? | As of today, Outset Medical has 354 employees. |
| Who is the CEO of Outset Medical? | Outset Medical's CEO is Ms. Leslie L. Trigg. |
| Is Outset Medical publicy listed? | Yes, Outset Medical is a public company listed on NAS. |
| What is the stock symbol of Outset Medical? | Outset Medical trades under OM ticker. |
| When did Outset Medical go public? | Outset Medical went public in 2020. |
| Who are competitors of Outset Medical? | Similar companies to Outset Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Outset Medical? | Outset Medical's current market cap is $193M |
| What is the current revenue of Outset Medical? | Outset Medical's last 12-month revenue is $116M. |
| What is the current EBITDA of Outset Medical? | Outset Medical's last 12-month EBITDA is -$64.6M. |
| What is the current EV/Revenue multiple of Outset Medical? | Current revenue multiple of Outset Medical is 2.0x. |
| What is the current EV/EBITDA multiple of Outset Medical? | Current EBITDA multiple of Outset Medical is -3.7x. |
| What is the current revenue growth of Outset Medical? | Outset Medical revenue growth between 2023 and 2024 was -13%. |
| Is Outset Medical profitable? | Yes, Outset Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
